A review of attention-deficit/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder

Journal of Developmental and Behavioral Pediatrics

Volumn 31, Issue 5, 2010, Pages 427-440

  Connor, Daniel F ^a   Steeber, Jennifer ^b   McBurnett, Keith ^c  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b Health Learning Systems   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

attention deficit hyperactivity disorder; comorbidity; conduct disorder; oppositional defiant disorder

Indexed keywords

ATTENTION DEFICIT DISORDER; COMORBIDITY; CONDUCT DISORDER; HUMAN; PREVALENCE; REVIEW; RISK FACTOR; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMPLICATION;

ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; CONDUCT DISORDER; HUMANS; PREVALENCE; RISK FACTORS;

EID: 77953867023     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/DBP.0b013e3181e121bd     Document Type: Review

References (90)

1. American Psychiatric Association. Attention-deficit and disruptive behavior disorders. In: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, Fourth Edition. Text Revision. Washington, DC: American Psychiatric Association; 2000:85-93.
2. Reiff MI, Stein MT. Attention-deficit/hyperactivity disorder evaluation and diagnosis. A practical approach in office practice. Pediatr Clin North Am. 2003;50:1019-1048.
3. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366:237-248.
4. Biederman J. Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry. 2005;57:1215-1220.
5. Centers for Disease Control and Prevention. Mental health in the United States: prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States, 2003. MMWR Morb Mortal Wkly Rep. 2005;54:842-847.
6. Pfiffner LJ. Comorbidity as an organizing principle. In: Keith McBurnett, Linda Pfiffner, eds. Attention Deficit Hyperactivity Disorder: Concepts, Controversies, New Directions. New York, NY: Informa HealthCare; 2007:51-61.
7. Steiner H, Remsing L; Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:126-141.
8. Lahey BB, Applegate B, Waldman ID, Loft JD, Hankin BL, Rick J. The structure of child and adolescent psychopathology: generating new hypotheses. J Abnorm Psychol. 2004;113:358-385.
9. Newcorn JH, Halperin JM. Attention-deficit disorders with oppositionality and aggression. In: Brown TE, ed. Attention- Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Washington, DC: American Psychiatric Press, Inc.; 2000:171-207.
10. Connor DF, Doerfler LA. ADHD with comorbid oppositional defiant disorder or conduct disorder; discrete or nondistinct disruptive behavior disorders? J Atten Disord. 2008;12:126-134.
11. Lahey BB, Loeber R, Burke J, Rathouz PJ, McBurnett K. Waxing and waning in concert: dynamic comorbidity of conduct disorder with other disruptive and emotional problems over 7 years among clinic-referred boys. J Abnorm Psychol. 2002;111: 556-567.
12. Burke JD, Loeber R, Lahey BB, Rathouz PJ. Developmental transitions among affective and behavioral disorders in adolescent boys. J Child Psychol Psychiatry. 2005;46:1200-1210.
13. Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry. 1998;59(suppl 7):50-58.
14. Lahey BB, Van Hulle CA, Rathouz PJ, Rodgers JL, D'Onofrio BM, Waldman ID. Are oppositional-defiant and hyperactiveinattentive symptoms developmental precursors to conduct problems in late childhood?: genetic and environmental links. J Abnorm Child Psychol. 2009;37:45-58.
15. Burke JD, Loeber R, Birmaher B. Oppositional defiant disorder and conduct disorder: a review of the past 10 years, part II. J Am Acad Child Adolesc Psychiatry. 2002;41:1275-1293.
16. Loeber R, Burke JD, Lahey BB, Winters A, Zera M. Oppositional defiant and conduct disorder: a review of the past 10 years, part I. J Am Acad Child Adolesc Psychiatry. 2000;39:1468-1484.
17. Pfiffner LJ, McBurnett K, Lahey BB, et al. Association of parental psychopathology to the comorbid disorders of boys with attention deficit-hyperactivity disorder. J Consult Clin Psychol. 1999;67:881-893.
18. Hartup WW. The development of aggression: where do we stand? In: Tremblay RE, Hartup WW, Archer J, eds. Developmental Origins of Aggression. New York, NY: The Guilford Press; 2005:3-22.
19. Odgers CL, Moffitt TE, Broadbent JM, et al. Female and male antisocial trajectories: from childhood origins to adult outcomes. Dev Psychopathol. 2008;20:673-716.
20. Moffitt TE. Adolescence-limited and life-course-persistent antisocial behavior: a developmental taxonomy. Psychol Rev. 1993;100:674-701.
21. Campbell SB, Spieker S, Burchinal M, Poe MD; NICHD Early Child Care Research Network. Trajectories of aggression from toddlerhood to age 9 predict academic and social functioning through age 12. J Child Psychol Psychiatry. 2006;47:791-800.
22. Coté SM, Vaillancourt T, LeBlanc JC, Nagin DS, Tremblay RE. The development of physical aggression from toddlerhood to pre-adolescence: a nation wide longitudinal study of Canadian children. J Abnorm Child Psychol. 2006;34:71-85.
23. Tremblay RE, Nagin DS, Seguin JR, et al. Physical aggression during early childhood: trajectories and predictors. Pediatrics. 2004;114:e43-e50.
24. Loeber R, Burke J, Pardini DA. Perspectives on oppositional defiant disorder, conduct disorder, and psychopathic features. J Child Psychol Psychiatry. 2009;50:133-142.
25. Biederman J, Faraone SV, Milberger S, et al. Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD. J Am Acad Child Adolesc Psychiatry. 1996;35:1193-1204.
26. Pliszka SR, Carlson CL, Swanson JM. Disruptive behavior disorders and substance abuse. In: ADHD With Comorbid Disorders: Clinical Assessment and Management. New York, NY: The Guilford Press; 1999:89-112.
27. Gorman EB, Klorman R, Thatcher JE, Borgstedt AD. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45:808-816.
28. Loeber R, Green SM, Lahey BB, Frick PJ, McBurnett K. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin Child Fam Psychol Rev. 2000;3:37-60.
29. Molina BS, Pelham WE Jr. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol. 2003;112:497-507.
30. Satterfield J, Swanson J, Schell A, Lee F. Prediction of antisocial behavior in attention-deficit hyperactivity disorder boys from aggression/defiance scores. J Am Acad Child Adolesc Psychiatry. 1994;33:185-190.
31. Barkley RA, Guevremont DC, Anastopoulos AD, DuPaul GJ, Shelton TL. Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics. 1993;92:212-218.
32. Harpold T, Biederman J, Gignac M, et al. Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD. J Nerv Ment Dis. 2007;195:601-605.
33. Pfiffner LJ, McBurnett K, Rathouz PJ. Father absence and familial antisocial characteristics. J Abnorm Child Psychol. 2001;29:357-367.
34. Werner EE. High-risk children in young adulthood: a longitudinal study from birth to 32 years. Am J Orthopsychiatry. 1989;59: 72-81.
35. Pfiffner LJ, McBurnett K, Rathouz PJ, Judice S. Family correlates of oppositional and conduct disorders in children with attention deficit/hyperactivity disorder. J Abnorm Child Psychol. 2005;33: 551-563.
36. Mikami AY, Pfiffner LJ. Sibling relationships among children with ADHD. J Atten Disord. 2008;11:482-492.
37. Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics. 2004;114: e541-e547.
38. Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:894-921.
39. Lahey BB, Applegate B, McBurnett K, et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry. 1994;151:1673-1685. (Pubitemid 24337603)
40. McBurnett K, Pfiffner LJ, Willcutt E, et al. Experimental crossvalidation of DSM-IV types of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999;38:17-24.
41. Lahey BB, Applegate B, Barkley RA, et al. DSM-IV field trials for oppositional defiant disorder and conduct disorder in children and adolescents. Am J Psychiatry. 1994;151:1163-1171. (Pubitemid 24240959)
42. Hart EL, Lahey BB, Loeber R, Hanson KS. Criterion validity of informants in the diagnosis of disruptive behavior disorders in children: a preliminary study. J Consult Clin Psychol. 1994;62: 410-414.
43. Conners CK. Conners' Rating Scales-Revised Technical Manual. North Tonawanda, NY: Multi-Health Systems Inc; 2001.
44. Swanson JM. The SNAP-IV Teacher and Parent Rating Scale. Available at: http://www.adhd.net/snap-iv-form.pdf. Accessed January 26, 2010.
45. Scoring Instructions for the SNAP-IV-C Rating Scale. Available at: http://www.adhd.net/snap-iv-instructions.pdf. Accessed January 26, 2010.
46. Conners CK. Conners Manual. 3rd ed. Ontario, Canada: Multi- Health Systems Inc.; 2008.
47. Gadow KD, Sprafkin J. Child Symptom Inventory: Ages 6 to 12 Years (CSI-4). Lutz, FL: Psychological Assessment Resources, Inc.; 2000.
48. Vanderbilt ADHD Diagnostic Parent Rating Scale. Available at: http://imaging.cmpmedica.com/CME/pt/PDF/VADPRS-Quest.pdf. Accessed January 26, 2010.
49. Vanderbilt ADHD Diagnostic Parent Rating Scale Scoring Instructions. Available at: http://imaging.cmpmedica.com/CME/ pt/PDF/VADPRS-Instructs.pdf. Accessed January 26, 2010.
50. Gadow KD, Sprafkin J, Carlson GA, et al. A DSM-IV-referenced, adolescent self-report rating scale. J Am Acad Child Adolesc Psychiatry. 2002;41:671-679.
51. Mathias CW, Stanford MS, Marsh DM, et al. Characterizing aggressive behavior with the Impulsive/Premeditated Aggression Scale among adolescents with conduct disorder. Psychiatry Res. 2007;151:231-242.
52. Burney DM, Kromrey J. Initial development and score validation of the Adolescent Anger Rating Scale. Educ Psychol Meas. 2001; 61:446-460.
53. Nelson WMI, Finch AJ Jr. Children's Inventory of Anger (ChIA) Manual. Los Angeles, CA: Western Psychological Services, 2000.
54. Achenbach System of Empirically Based Assessment. Youth Self Report/11-18. Burlington, VT: Achenbach System of Empirically Based Assessment; 2009.
55. Findling RL, Connor DF, Wigal T, Eagan C, Onofrey MN. A linguistic analysis of in-office dialogue among psychiatrists, parents and child and adolescent patients with ADHD. J Atten Disord. 2009;13:78-86.
56. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40:147-158.
57. Klein RG, Abikoff H, Hechtman L, Weiss G. Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2004;43:792-801. (Pubitemid 38808484)
58. Abikoff H, Hechtman L, Klein RG, et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004;43:802-811. (Pubitemid 38808485)
59. Spencer TJ, Abikoff HB, Connor DF, et al. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/ hyperactivity disorder in school-aged children and adolescents: a 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-doseescalation study. Clin Ther. 2006;28:402-418.
60. Newcorn JH, Spencer TJ, Biederman J, Milton DR, Michelson D. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:240-248.
61. Strattera [package insert]. Indianapolis, IN: Eli Lilly and Company; 2009.
62. Michelson D, Faries D, Wernicke J, et al; Atomoxetine ADHD Study Group. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics. 2001;108:E83.
63. Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999;38:1551-1559.
64. Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40:922-928.
65. Evans SW, Schultz BK, Sadler JM. Safety and efficacy of psychosocial interventions used to treat children with attentiondeficit/ hyperactivity disorder. Pediatr Ann. 2008;37:52-59.
66. American Academy of Pediatrics. Subcommittee on Attention- Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/ hyperactivity disorder. Pediatrics. 2001;108:1033-1044.
67. Pelham WEJ, Fabiano GA. Behavior modification. Child Adolesc Psychiatr Clin North Am. 2000;9:671-688.
68. Barkley RA. Defiant Children: A Clinician's Manual for Assessment and Parent Training. 2nd ed. New York, NY: Guilford Press; 1997.
69. Young S, Myanthi AJ. Practitioner review: non-pharmacological treatments for ADHD: a lifespan approach. J Child Psychol Psychiatry. 2009;51:116-133.
70. Eyberg SM, Nelson MM, Boggs SR. Evidence-based psychosocial treatments for children and adolescents with disruptive behavior. J Clin Child Adolesc Psychol. 2008;37:215-237.
71. Pliszka SR. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management. Paediatr Drugs. 2003;5:741-750.
72. Patterson GR, Dishion TJ, Yoerger K. Adolescent growth in new forms of problem behavior: macro- and micro-peer dynamics. Prev Sci. 2000;1:3-13.
73. Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry. 1997;36:754-763.
74. van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM. Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD? Eur Child Adolesc Psychiatry. 2007;16:48-57.
75. Pelham WE, Aronoff HR, Midlam JK, et al. A comparison of Ritalin® and Adderall® : efficacy and time-course in children with attention-deficit/ hyperactivity disorder. Pediatrics. 1999;103:e43.
76. Gadow KD, Nolan EE, Sverd J, Sprafkin J, Schneider J. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD. J Child Neurol. 2008;23:981-990.
77. Bangs ME, Hazell P, Danckaerts M, et al; Atomoxetine ADHD/ ODD Study Group. Atomoxetine for the treatment of attentiondeficit/ hyperactivity disorder and oppositional defiant disorder. Pediatrics. 2008;121:e314-e320.
78. Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Psychiatry. 1985;24:617-629.
79. Connor DF, Barkley RA, Davis HT. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr. 2000;39:15-25.
80. Palumbo DR, Sallee FR, Pelham WE Jr, Bukstein OG, Daviss WB, McDermott MP. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47:180-188.
81. Kaplan S, Heiligenstein J, West S, et al. Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder. J Atten Disord. 2004;8:45-52.
82. Cheng JY, Chen RY, Ko JS, Ng EM. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta- analysis and meta-regression analysis. Psychopharmacology (Berl). 2007;194:197-209.
83. Connor DF, Glatt SJ, Lopez ID, Jackson D, Melloni RH Jr. Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41:253-261.
84. Biederman J, Spencer TJ, Newcorn JH, et al. Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data. Psychopharmacology (Berl). 2007; 190:31-41.
85. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/ hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther. 2006;28:266-279.
86. Daviss WB, Patel NC, Robb AS, et al. Clonidine for attentiondeficit/ hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry. 2008;47: 189-198.
87. Intuniv [package insert]. Wayne, PA: Shire Pharmaceuticals Inc.; 2009.
88. Biederman J, Melmed RD, Patel A, et al; SPD503 Study Group. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics. 2008;121: e73-e84.
89. Sallee F, McGough J, Wigal T, Donahue J, Lyne A, Biederman J; SPD503 Study Group. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009;48:155-165.
90. Lahey BB, Rathouz PJ, Van Hulle C, et al. Testing structural models of DSM-IV symptoms of common forms of child and adolescent psychopathology. J Abnorm Child Psychol. 2008;36: 187-206.